BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Pharmacogenetics, Rosiglitazone, rs2476601, TGFB1, cell-cell adhesion, Arthritis)
Bookmark Forward

QuickView for CXCR2 (gene)


Body Atlas

Most Correlated Tissues

  1. Leukocyte (polymorphonuclear) of peripheral blood
  2. Neutrophil of bone marrow
  3. Whole blood
  4. Mononuclear cell of peripheral blood
  5. Basophil of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Hypercapnia
  2. Festuca arundinacea poisoning
  3. Injury of lung
  4. Tularemia
  5. Anxiety disorder
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Histamine H2 Antagonists
  2. Histamine H1 Antagonists
  3. Zymosan
  4. shikonin
  5. Metolazone
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. TICAM1
  2. PERP
  3. TBX21
  4. FUBP3
  5. ADAM17
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Structural insights into the activation of chemokine receptor CXCR2.
  2. CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma.
  3. Effect of interleukin-8 receptor B (IL8RB) rs1126579 C>T variation on the risk to cancer.
  4. CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negativ…
  5. CXCR2 inhibition enables NASH-HCC immunotherapy.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer
  2. Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients…
  3. AZD5069 Neutrophil Function Study
  4. Pharmacokinetics and Safety of GSK1325756 in Elderly Subjects and Adult Subjects of in the Fed and F…
  5. Combination Study of AZD5069 and Enzalutamide.
Explore Clinical Trials Results
  • Copyright © 2022 Illumina Inc. All rights reserved.